Project Description

The National Health Services (NHS) Blood and Transplant recently announced that the world’s first human clinic trial for synthetic blood will be ready for testing in 2017 as part of the 2020 Research and Development program’s blood and organ service.

The NHS Blood and Transplant is a joint Special Health Authority for England and Wales and is the organ donor organization responsible for matching and allocating organ donations in the UK. To facilitate the use of synthetic blood, it is planning on partnering with leading universities to develop transplantation, transfusion and regenerative medicine within the next five years.

Learn more